The Impact of Standard Medical Care (Dopamine) and Practice on Postural Motor Learning in Parkinson's Disease
Completed · Not applicable
Conditions studied: Parkinson Disease
In brief
The study determines whether standard medical care (dopamine) affects learning and retention of a postural stepping task in people with Parkinson's disease (PD) and whether training on a postural stepping task generalises to performance on an untrained postural task. Half the participants will train on the stepping task after they have taken their first dose of dopamine for the day (i.e. "on" medication state) while the other half will train on the same stepping task before taking their first daily dose of dopamine (i.e. "off" medication state).
Key facts
- Study ID
- NCT02593812
- Run by
- University of Utah
- People needed
- 27
- Starts
- 2016-07-01
- Expected to finish
- 2017-05-11
- Last updated by the study team
- 2018-02-22
Who can join
Age: 50 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Idiopathic Parkinson's disease confirmed by neurologist
- Hoehn and Yahr stages 1 to 3
- On a stable dose of antiparkinsonian medication for the past month and will continue on this regime for at least another subsequent month
- Walks unaided
You may not qualify if…
- Not taking dopamine replacement therapy
- With prior surgical management for PD (e.g. deep brain stimulation)
- With medication-resistant freezing of gait
- Significant cognitive impairment (Montreal Cognitive Assessment score <18)
- Unstable medical conditions
- Other neurological conditions
- Unable to follow instructions or safely complete the training tasks
Where it is running
- University of Utah — Salt Lake City, Utah, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.